Where does Delfi Diagnostics's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Delfi Diagnostics's 1 recorded funding rounds.

Premier Alternatives

Delfi Diagnostics

Palo Alto, CA · Founded 2019 · Privately Held (backing)

Developer of a blood test system designed for the early detection of cancer. Delfi Diagnostics is based in Palo Alto, CA and was founded in 2019. Its last reported valuation was $725 million in Jun 2024. It has raised $466 million across 1 recorded round; the latest was a $34.3 million debt round in Dec 2025.

Last reported valuation

$725.0M

Oct 2026

Priced at

—

Total raised

$465.9M

Last round

Debt

Dec 2025

Cap table — not yet on record

Delfi Diagnostics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Delfi Diagnostics with a free account

·The complete investor list: 27 names
·Watch Delfi Diagnostics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Delfi Diagnostics

Where does Delfi Diagnostics's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Delfi Diagnostics's 1 recorded funding rounds.